YF476 in Patients With Type II Gastric Carcinoids Associated With Zollinger-Ellison Syndrome
Condition:   CarcinoidIntervention:   Drug: YF476Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2011 Category: Research Source Type: clinical trials

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
Conditions:   Gastrinoma;   Zollinger Ellison SyndromeIntervention:   Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 1999 Category: Research Source Type: clinical trials